[MHC class II deficiency (CIITA/RFX deficiency)].
Morio
T
T
Division of Human Ontogeny and Childhood Development, Graduate School, Tokyo Medical and Dental University.
D004268:DNA-Binding Proteins / Q000235:genetics; D003937:Diagnosis, Differential; D005802:Genes, MHC Class II; D018380:Hematopoietic Stem Cell Transplantation; D000949:Histocompatibility Antigens Class II; D006801:Humans; D009154:Mutation; D009687:Nuclear Proteins; D011379:Prognosis; D000071701:Regulatory Factor X Transcription Factors; D016511:Severe Combined Immunodeficiency / Q000145:classification / Q000209:etiology; D015534:Trans-Activators / Q000235:genetics; D014157:Transcription Factors / Q000235:genetics
D004268:DNA-Binding Proteins; D000949:Histocompatibility Antigens Class II; C083728:MHC class II transactivator protein; D009687:Nuclear Proteins; D000071701:Regulatory Factor X Transcription Factors; D015534:Trans-Activators; D014157:Transcription Factors